Clarification11 Sept 2026, 10:11 am
Astec Lifesciences Responds to BSE on Volume Increase
AI Summary
Astec Lifesciences Ltd has responded to a BSE email dated September 10, 2026, regarding a significant increase in the volume of its securities. The company affirmed its commitment to timely dissemination of price-sensitive information as per SEBI Listing Regulations. Astec Lifesciences confirmed compliance with disclosure requirements under the Listing Regulations and the PIT Regulations, stating there are no undisclosed material developments requiring mandatory disclosure. The company assured continued adherence to regulatory obligations and appropriate disclosures as and when required.
Key Highlights
- Company responds to BSE query on stock volume increase.
- Confirms compliance with SEBI Listing Obligations and Disclosure Requirements.
- No material developments requiring mandatory disclosure.
- Reaffirms commitment to regulatory compliance and timely disclosures.
Price Impact
More from ASTEC